Oral Abstract Session 10: Islets I
Abstract:A-10-1 Elevation of Cytotoxic Lymphocyte Gene Expression Is Predictive of Islet Allograft Rejection in Non-Human Primates Dongmei Han, Xiumin Xu, R. Alejandro, C. Ricordi, and N. S. Kenyon
A-10-2 Effect of Vascular Endothelial Growth Factor Delivery on the Viability of Encapsulated Pancreatic Rat Islets During Allo- and Xenograft S. Sigrist, A. Mechine-Neuville, V. Calenda, G. Legeay, J-P. Bellocq, A. Belcourt, M. Pinget, and L. Kessler
A-10-3 Bioartificial Pancreas: Matching Device and β-Cell Engineering H. Hussain-Khan, N. Bouche, P. Aebischer, and W. F. Pralong
A-10-4 Chronic Complications of Diabetes Prevent Islet Engraftment at Three Transplantation Sites Wayne V. Moore, Karen Bieser, Zhaohui Geng, and Karen Kover
A-10-5 Vascular Density in Mouse Pancreatic Islets Decreases After Transplantation Goran Mattson, Leif Jansson, and Per-Ola Carlsson
A-10-6 Protein Permeability in Biodritin (Alginate + Chondroitin Sulfate) Microcapsules for Islet Transplantation Melina Ribeiro, Camillo Ricordi, and Marcos Mares-Guia
A-10-7 Amelioration Streptozotocin Induced Diabetic Mice With Human Islet Cells Derived From Long Term Culture In Vitro Min Zhao, Mike Christie, Nigel Heaton, Sarah George, Stephanie Amiel, and Guocai Huang
A-10-8 Cytokines Induce Nitric Oxide (NO) and NF· B Independent Expression of Pro-inflammatory Chemokines in Both Murine Islets and MIN6-· Cells Marshall S. Baker, Xiiojan Chen, and Dixon B. Kaufman
Document Type: Abstract
Publication date: June 1, 2001
More about this publication?
- Cell Transplantation publishes original, peer-reviewed research and review articles on the subject of cell transplantation and its application to human diseases. To ensure high-quality contributions from all areas of transplantation, separate section editors and editorial boards have been established. Articles deal with a wide range of topics including physiological, medical, preclinical, tissue engineering, and device-oriented aspects of transplantation of nervous system, endocrine, growth factor-secreting, bone marrow, epithelial, endothelial, and genetically engineered cells, among others. Basic clinical studies and immunological research papers are also featured. To provide complete coverage of this revolutionary field, Cell Transplantation will report on relevant technological advances, and ethical and regulatory considerations of cell transplants. Cell Transplantation is now an Open Access journal starting with volume 18 in 2009, and therefore there will be an inexpensive publication charge, which is dependent on the number of pages, in addition to the charge for color figures. This will allow work to be disseminated to a wider audience and also entitle the corresponding author to a free PDF, as well as prepublication of an unedited version of the manuscript.